Glenn Goddard, EVP, Chief Financial Officer at Intellia Therapeutics, Inc. (NTLA), sold 6,964 shares at $180.12 ($1.3M) on 2021-09-07, disclosed to the SEC on 2021-09-09.
Open-market sale of $1.3M NTLA by EVP, Chief Financial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $180.12 | 3,482 | $627K | 50.0% |
| 2 | $180.12 | 3,482 | $627K | 50.0% |
| Total | $180.12 avg | 6,964 | $1.3M | 100% |
| Filing → |
| NTLA | SELL | 2022-03-03 | $227K | — | Filing → |
| NTLA | SELL | 2021-09-01 | $5.0M | — | Filing → |
| NTLA | SELL | 2021-08-06 | $6.0M | — | Filing → |